NCT01674140 2026-02-10
e3
SWOG Cancer Research Network
Phase 3 Active not recruiting
Clinical Trials
4 trialsNCT01824836 2025-05-31
A Study to Evaluate Genetic Predictors of Aromatase Inhibitor Musculoskeletal Symptoms (AIMSS)
Eastern Cooperative Oncology Group
Phase NA Active not recruiting
NCT00295646 2024-03-15
Tamoxifen Versus Anastrozole, Alone or in Combination With Zoledronic Acid
Austrian Breast & Colorectal Cancer Study Group
Phase 3 Completed
NCT00066573 2023-08-25
Exemestane or Anastrozole in Treating Postmenopausal Women Who Have Undergone Surgery for Primary Breast Cancer
Canadian Cancer Trials Group
Phase 3 Completed